Bibliography
- TIJAN R, MANIATIS T: Transcriptional activation: a com-plex puzzle with few easy pieces. Cell (1994) 77:5–8.
- PABO C, SAUER R: Transcription factors: structural fami-lies and principles of DNA recognition. Ann. Rev. Bio-chem. (1992) 61:1053–1095.
- MANNING AM: Transcription factors: a new frontier for drug discovery. Drug Discover)/ Today (1995) 1:151–160.
- LEWIS AJ: Transcription factors: new targets for drug discovery. In: Emerging drugs: the prospect for improved medicines. Bowman WC, Fitzgerald JD, Taylor JB (Eds.), Ashley Publications Ltd., London (1996).
- SHEPHERD J, COBBE SM, FORD I et al.: Prevention ofcoronary heart disease with pravastatin in men with hyper choles ter olaemia. West of Scotia nd Coronary Pre - vention Study Group. New Eng. J. Med. (1995) 333:1301–1307.
- YANG J, BROWN MS, HO YK, GOLDSTEIN JL: Three different rearrangements in a single intron truncate sterol regulatory element binding protein-2 and pro-duce sterol-resistant phenotype in three cell lines. J. Biol. Chem. (1995) 270:12152–12161.
- PILLAI R: Oncogene expression and prognosis in cervi-cal cancer. Cancer Lett. (1991) 59:171–175.
- HO LLSTEIN M, SIDRANSKY D, VOGELSTEIN B, HARRIS CC:p53 mutations in human cancers. Science (1991) 253:49–53.
- HUMANS EM, VOORHOEVE PM, BEIJERSBERGEN RL, VAN'TVEER LJ, BERNARDS R: E2F-5, a new family member that interacts with p130 in vivo. Mol . Cell. Biol (1995) 15:3082–3089.
- SARKAR FH, SMITH MR, HOOVER T et al: c-erb-2 pro-moter-specific DNA binding protein isolated from hu-man breast cancer tissues displays mitogenic activity. J. Biol. Chem. (1994) 269:12285–12289.
- DARNELL JE, KERR IM, STARK GR: Jak-STAT pathways and transcriptional activation in response to IENs and other extracellular signalling proteins. Science (1994) 264:1415–1421.
- ROSEN J, DAY A, JONES ETT, NADZAN AM, STEIN RB:Intracellular receptors and signal transducers and acti-vators of transcription superfamilies: novel targets for small-molecule drug discovery. J Med. Chem. (1995) 38:4855–4874.
- HOU J, SCHINDLER U, HENZEL WJ et al: An interleukin-4-induced transcription factor: IL-4 Stat. Science (1994) 265: 1701-1706.
- KAWAI S, TAKESHITA S, OKAZAKI M et al: Cloning andcharacterisation of OSF-3, a new member of the MER5 family, expressed in mouse osteoblastic cells. J. Bio-chem. (1994) 115:641–642.
- MANGELSDORF DJ, THUMMFL C, BEATO M et al: Thenuclear receptor superfamily: the second decade. Cell (1995) 83:835–839.
- DRAPER MW, FLOWERS DE, NEILD JA, HUSTER WJ, ZERBE RL: Anti-oestrogenic effects of raloxifene. Pharmacology (1995) 50:209–217.
- YANG NN, BRYANT HU, HA RDIKAR S eta].: Oestrogen and raloxifene stimulate transforming growth factor-13 3 gene expression in rat bone: a potential mechanism for oestrogen- and raloxifene -mediated bone mainte-nance. Endocrinology (1996) 137:2075–2084.
- TODD MD, LEE MJ, WILLIAMS JL eta].: The CAT-Tox assay: a sensitive measure of stress-induced transcription in transformed human liver cells. Fundam. App. Toxicol (1995) 28:118–128.
- SPENCER DM: Creating conditional mutants in mam-mals. Trends Genet (1996) 12:181–187.
- RIVERA VM, CLACKSON T, NATESAN S et al: A humanised system for pharmacologic control of gene expression. Nat Med (1996) 2:1028–1032.
- HO SN, BIGGAR SR, SPENCER DM, SCHREIBER SL, CRAB-TREE GR: Controlling transcription with synthetic li-gands. Nature (1996) In press.
- WEISCHSELBAUM RR, HALLAHAN D, FUKS Z, KUFE D: Radiation induction of immediate early genes: effectors of the radiation-stress response. mt. J. Rad. Oncol Biol. Phys. (1994) 30:229–234.
- SEUNG LP, MAUCERI HJ, BECKETT MA et al.: Genetic radiotherapy overcomes tumour resistance to cytotoxic agents. Cancer Res. (1995) 55:5561–5565.
- HENDRICKS-TAYLOR LR, DARLINGTON GJ: Inhibition of cell proliferation by C/EBP a occurs in many cell types, does not require the presence of p53 or Rb, and is not affected by large T-antigen. Nuc. Acids Res. (1995) 23:4726–4733.